A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity

NCT07243171 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and/or Obesity
Weight Management

Interventions

DRUG: ecnoglutide tablets
DRUG: placebo with matching dosage

Sponsor

Hangzhou Sciwind Biosciences Co., Ltd.